Download PDF
CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2018; 37(01): 58-62
DOI: 10.1055/s-0038-1625979
Case Report | Relato de Caso
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Pseudotumor Cerebri Presenting Unilateral Papilledema Associated with Iron-deficiency Anemia

Pseudotumor cerebral apresentando papiledema unilateral associado a anemia ferropriva
Fernando Antônio de Oliveira Costa
1   Escola Paulista de Medicina, Pelotas, Rio Grande do Sul, Brazil
,
Othello Moreira Fabião Neto
1   Escola Paulista de Medicina, Pelotas, Rio Grande do Sul, Brazil
,
Guilherme Gago
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Otávio Garcia Martins
3   Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Frederico de Lima Gibbon
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
,
Leonardo Mendes Nogueira
2   Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil
› Author Affiliations
Further Information

Publication History

29 September 2017

18 December 2017

Publication Date:
08 March 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Pseudotumor cerebri is a relatively common pathology that is characterized by intracranial hypertension in the absence of mass lesions. It commonly affects young and obese women, and its presentation with visual loss and bilateral papilledema is well-described in the literature. We present a case of a 44-year-old, non-obese, female patient presenting with unilateral papilledema and iron-deficiency anemia. This case emphasizes this unusual presentation and the rare association with iron deficiency.

Resumo

O pseudotumor cerebral é uma patologia relativamente comum, caracterizada pela hipertensão intracraniana na ausência de lesões causando efeito de massa. Frequentemente afeta mulheres jovens e obesas, e sua apresentação, com perda do campo visual e papiledema bilateral, é bem descrita na literatura. Nós apresentamos um caso de uma paciente de 44 anos, não obesa, com papiledema unilateral e anemia ferropriva. Esse caso destaca essa apresentação incomum e a rara associação com a deficiência de ferro.

Keywords

pseudotumor cerebri - idiopathic intracranial hypertension - unilateral papilledema - iron-deficiency anemia

Palavras-chave

pseudotumor cerebral - hipertensão intracraniana idiopática - papiledema unilateral - anemia ferropriva
 

  • References

  • 1 Corbett J. Idiopathic intracranial hypertension. J Neuroophthalmol 2012; 32 (03) e4-e6
    CrossrefPubMedGoogle Scholar
  • 2 Corbett JJ. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983; 10 (04) 221-229
    CrossrefPubMedGoogle Scholar
  • 3 Daniels AB, Liu GT, Volpe NJ. , et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007; 143 (04) 635-641
    CrossrefPubMedGoogle Scholar
  • 4 Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45 (08) 875-877
    CrossrefPubMedGoogle Scholar
  • 5 Friedman DI. Idiopathic intracranial hypertension with Dan and beyond: the 2010 Jacobson Lecture. J Neuroophthalmol 2010; 30 (04) 380-385
    CrossrefPubMedGoogle Scholar
  • 6 Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc 1994; 69 (02) 169-180
    CrossrefPubMedGoogle Scholar
  • 7 Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50 (01) 78-80
    CrossrefPubMedGoogle Scholar
  • 8 Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114 (Pt 1A): 155-180
    PubMedGoogle Scholar
  • 9 Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010; 74 (22) 1827-1832
    CrossrefPubMedGoogle Scholar
  • 10 Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78 (01) 89-94
    CrossrefPubMedGoogle Scholar
  • 11 Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45 (08) 866-872
    CrossrefPubMedGoogle Scholar
  • 12 Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002; 109 (03) 482-485
    CrossrefPubMedGoogle Scholar
  • 13 Johnston I, Kollar C, Dunkley S, Assaad N, Parker G. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 2002; 9 (03) 273-278
    CrossrefPubMedGoogle Scholar
  • 14 Balcer LJ, Liu GT, Forman S. , et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52 (04) 870-872
    CrossrefPubMedGoogle Scholar
  • 15 Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127 (02) 178-182
    CrossrefPubMedGoogle Scholar
  • 16 Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47 (03) 315-320
    CrossrefPubMedGoogle Scholar
  • 17 Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41 (2 Pt 1): 239-244
    CrossrefPubMedGoogle Scholar
  • 18 Tugal O, Jacobson R, Berezin S. , et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 1994; 16 (03) 266-270
    CrossrefPubMedGoogle Scholar
  • 19 Wall M, Kupersmith MJ, Kieburtz KD. , et al; NORDIC Idiopathic Intracranial Hypertension Study Group. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 2014; 71 (06) 693-701
    CrossrefPubMedGoogle Scholar
  • 20 Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980; 55 (09) 541-546
    PubMedGoogle Scholar
  • 21 Sklar FH, Reisch J, Elashvili I, Smith T, Long DM. Effects of pressure on cerebrospinal fluid formation: nonsteady-state measurements in dogs. Am J Physiol 1980; 239 (03) R277-R284
    PubMedGoogle Scholar
  • 22 Welch K. The principles of physiology of the cerebrospinal fluid in relation to hydrocephalus including normal pressure hydrocephalus. Adv Neurol 1975; 13: 247-332
    PubMedGoogle Scholar
  • 23 Sahar A. The effect of pressure on the production of cerebrospinal fluid by the choroid plexus. J Neurol Sci 1972; 16 (01) 49-58
    CrossrefPubMedGoogle Scholar
  • 24 Donaldson JO. Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc 1979; 104: 196-198
    PubMedGoogle Scholar
  • 25 Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974; 97 (02) 301-312
    CrossrefPubMedGoogle Scholar
  • 26 Mann JD, Johnson RN, Butler AB, Bass NH. Cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid therapy. Neurology 1979; 29: 550
    CrossrefPubMedGoogle Scholar
  • 27 Gjerris F, Soelberg Sørensen P, Vorstrup S, Paulson OB. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol 1985; 17 (02) 158-162
    CrossrefPubMedGoogle Scholar
  • 28 Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15 (03) 168-174
    CrossrefPubMedGoogle Scholar
  • 29 Alperin N, Ranganathan S, Bagci AM. , et al. MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2013; 34 (01) 29-34
    CrossrefPubMedGoogle Scholar
  • 30 Alperin N, Lam BL, Tain R-W. , et al. Evidence for altered spinal canal compliance and cerebral venous drainage in untreated idiopathic intracranial hypertension. Acta Neurochir Suppl (Wien) 2012; 114: 201-205
    PubMedGoogle Scholar
  • 31 Farb RI, Vanek I, Scott JN. , et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003; 60 (09) 1418-1424
    CrossrefPubMedGoogle Scholar
  • 32 Rohr A, Dörner L, Stingele R, Buhl R, Alfke K, Jansen O. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007; 28 (04) 656-659
    PubMedGoogle Scholar
  • 33 King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002; 58 (01) 26-30
    CrossrefPubMedGoogle Scholar
  • 34 Kanagalingam S, Subramanian PS. Cerebral venous sinus stenting for pseudotumor cerebri: A review. Saudi J Ophthalmol 2015; 29 (01) 3-8
    CrossrefPubMedGoogle Scholar
  • 35 Mollan SP, Ball AK, Sinclair AJ. , et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol 2009; 62 (02) 105-108
    CrossrefPubMedGoogle Scholar
  • 36 Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990; 10 (06) 331-335
    CrossrefPubMedGoogle Scholar
  • 37 Corbett JJ, Savino PJ, Thompson HS. , et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39 (08) 461-474
    CrossrefPubMedGoogle Scholar
  • 38 Sismanis A, Butts FM, Hughes GB. Objective tinnitus in benign intracranial hypertension: an update. Laryngoscope 1990; 100 (01) 33-36
    PubMedGoogle Scholar
  • 39 Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998; 51 (01) 245-249
    CrossrefPubMedGoogle Scholar
  • 40 Rudnick E, Sismanis A. Pulsatile tinnitus and spontaneous cerebrospinal fluid rhinorrhea: indicators of benign intracranial hypertension syndrome. Otol Neurotol 2005; 26 (02) 166-168
    CrossrefPubMedGoogle Scholar
  • 41 Chari C, Rao NS. Benign intracranial hypertension--its unusual manifestations. Headache 1991; 31 (09) 599-600
    CrossrefPubMedGoogle Scholar
  • 42 Wall M, White II WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998; 39 (01) 134-142
    PubMedGoogle Scholar
  • 43 Greenfield DS, Wanichwecharungruang B, Liebmann JM, Ritch R. Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy. Arch Ophthalmol 1997; 115 (03) 423-426
    CrossrefPubMedGoogle Scholar
  • 44 Quattrone A, Bono F, Fera F, Lavano A. Isolated unilateral abducens palsy in idiopathic intracranial hypertension without papilledema. Eur J Neurol 2006; 13 (06) 670-671
    CrossrefPubMedGoogle Scholar
  • 45 Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Anemia and papilledema. Am J Ophthalmol 2003; 135 (04) 437-446
    CrossrefPubMedGoogle Scholar
  • 46 Mark S. . Greenberg. Handbook of Neurosurgery. Eighth. Vol. 81, The Yale journal of biology and medicine. New York: Thieme; 2008
    Google Scholar
  • 47 Galgano MA, Deshaies EM. An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg 2013; 115 (03) 252-259
    CrossrefPubMedGoogle Scholar
  • 48 Thurtell MJ, Bruce BB, Newman NJ, Biousse V. An update on idiopathic intracranial hypertension. Rev Neurol Dis 2010; 7 (2-3): e56-e68
    PubMedGoogle Scholar
  • 49 Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia 2015; 35 (03) 248-261
    CrossrefPubMedGoogle Scholar
  • 50 Johnson LN, Krohel GB, Madsen RW, March Jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105 (12) 2313-2317
    CrossrefPubMedGoogle Scholar
  • 51 Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004; 63 (09) 1737-1739
    CrossrefPubMedGoogle Scholar
  • 52 Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994; 118 (01) 88-96
    CrossrefPubMedGoogle Scholar